Cargando…
The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections
BACKGROUND: Enhanced recovery after thoracic surgery (ERATS) protocols use a combination of analgesics for pain control. We investigated the effect of non-steroidal analgesic drugs (NSAIDs) on pain control by comparing patient levels and opioid requirements after robotic pulmonary resections. METHOD...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586992/ https://www.ncbi.nlm.nih.gov/pubmed/37868875 http://dx.doi.org/10.21037/jtd-23-709 |
_version_ | 1785123261601808384 |
---|---|
author | Gross, Daniel J. Kodia, Karishma Alnajar, Ahmed Villamizar, Nestor R. Nguyen, Dao M. |
author_facet | Gross, Daniel J. Kodia, Karishma Alnajar, Ahmed Villamizar, Nestor R. Nguyen, Dao M. |
author_sort | Gross, Daniel J. |
collection | PubMed |
description | BACKGROUND: Enhanced recovery after thoracic surgery (ERATS) protocols use a combination of analgesics for pain control. We investigated the effect of non-steroidal analgesic drugs (NSAIDs) on pain control by comparing patient levels and opioid requirements after robotic pulmonary resections. METHODS: We retrospectively analyzed our prospectively maintained institutional database for elective, opioid-naïve robotic thoracoscopic pulmonary resections. All patients received postoperative NSAIDs unless contraindicated or at the discretion of the attending surgeons. Our original protocol (ERATS-V1) was modified to optimize opioid-sparing effect without affecting pain control (ERATS-V2). Demographics, operative outcomes, and postoperative opioid dispensed [morphine milligram equivalent (MME)] were collected. RESULTS: A total of 491 patients (147 ERATS-V1; 344 ERATS-V2) were included in this study. There was no difference in patient characteristics or operative outcomes between ERATS cohorts. Protocol optimization was associated with a 2- to 10-fold reduction of postoperative opioid use without compromising pain control. In ERATS-V1 cohort, there was no difference in pain levels and opioid requirements with NSAID usage. In ERATS-V2 cohort, while pain levels were similar, higher in-hospital opioid consumption was observed in no-NSAID subgroup {MME: 20.5 [interquartile range (IQR), 4.8–40.5] vs. 12.0 (IQR, 2.0–32.2), P=0.0096, schedule II: 14.2 (IQR, 3.0–36.4) vs. 6.8 (IQR, 1.4–24.0), P=0.012} as well as total postoperative schedule II opioid requirement [17.8 (IQR, 3.0–43.5) vs. 8.8 (IQR, 1.5–30), P=0.032]. CONCLUSIONS: The opioid-sparing effect of NSAIDs was observed only in optimized ERATS patients. Modifications of our pre-existing ERATS was associated with a significant reduction of opioid consumption without affecting pain levels. This revealed the role of NSAIDs in postoperative pain management otherwise masked by excessive opioids use. |
format | Online Article Text |
id | pubmed-10586992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-105869922023-10-21 The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections Gross, Daniel J. Kodia, Karishma Alnajar, Ahmed Villamizar, Nestor R. Nguyen, Dao M. J Thorac Dis Original Article BACKGROUND: Enhanced recovery after thoracic surgery (ERATS) protocols use a combination of analgesics for pain control. We investigated the effect of non-steroidal analgesic drugs (NSAIDs) on pain control by comparing patient levels and opioid requirements after robotic pulmonary resections. METHODS: We retrospectively analyzed our prospectively maintained institutional database for elective, opioid-naïve robotic thoracoscopic pulmonary resections. All patients received postoperative NSAIDs unless contraindicated or at the discretion of the attending surgeons. Our original protocol (ERATS-V1) was modified to optimize opioid-sparing effect without affecting pain control (ERATS-V2). Demographics, operative outcomes, and postoperative opioid dispensed [morphine milligram equivalent (MME)] were collected. RESULTS: A total of 491 patients (147 ERATS-V1; 344 ERATS-V2) were included in this study. There was no difference in patient characteristics or operative outcomes between ERATS cohorts. Protocol optimization was associated with a 2- to 10-fold reduction of postoperative opioid use without compromising pain control. In ERATS-V1 cohort, there was no difference in pain levels and opioid requirements with NSAID usage. In ERATS-V2 cohort, while pain levels were similar, higher in-hospital opioid consumption was observed in no-NSAID subgroup {MME: 20.5 [interquartile range (IQR), 4.8–40.5] vs. 12.0 (IQR, 2.0–32.2), P=0.0096, schedule II: 14.2 (IQR, 3.0–36.4) vs. 6.8 (IQR, 1.4–24.0), P=0.012} as well as total postoperative schedule II opioid requirement [17.8 (IQR, 3.0–43.5) vs. 8.8 (IQR, 1.5–30), P=0.032]. CONCLUSIONS: The opioid-sparing effect of NSAIDs was observed only in optimized ERATS patients. Modifications of our pre-existing ERATS was associated with a significant reduction of opioid consumption without affecting pain levels. This revealed the role of NSAIDs in postoperative pain management otherwise masked by excessive opioids use. AME Publishing Company 2023-08-31 2023-09-28 /pmc/articles/PMC10586992/ /pubmed/37868875 http://dx.doi.org/10.21037/jtd-23-709 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Gross, Daniel J. Kodia, Karishma Alnajar, Ahmed Villamizar, Nestor R. Nguyen, Dao M. The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections |
title | The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections |
title_full | The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections |
title_fullStr | The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections |
title_full_unstemmed | The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections |
title_short | The essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections |
title_sort | essential role of non-steroidal anti-inflammatory drugs in pain control following robotic thoracoscopic lung resections |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586992/ https://www.ncbi.nlm.nih.gov/pubmed/37868875 http://dx.doi.org/10.21037/jtd-23-709 |
work_keys_str_mv | AT grossdanielj theessentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT kodiakarishma theessentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT alnajarahmed theessentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT villamizarnestorr theessentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT nguyendaom theessentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT grossdanielj essentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT kodiakarishma essentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT alnajarahmed essentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT villamizarnestorr essentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections AT nguyendaom essentialroleofnonsteroidalantiinflammatorydrugsinpaincontrolfollowingroboticthoracoscopiclungresections |